Afinion Hba1c Dx
Payments companies reported to CMS as associated with Afinion Hba1c Dx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Afinion Hba1c Dx, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Afinion Hba1c Dx
These are the largest totals companies reported as associated with Afinion Hba1c Dx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Aaron King | San Antonio, TX | Family Medicine | $4,594.48 |
| Kwabena Adubofour | Stockton, CA | Internal Medicine | $1,000.00 |
| Jay Shubrook | Vallejo, CA | Family Medicine | $875.00 |
| Vivian Fonseca | New Orleans, LA | Endocrinology, Diabetes & Metabolism | $675.00 |
| Olugbemiga Jegede | Greensboro, NC | Internal Medicine | $206.98 |
| Michael Ackerman | Warrenton, VA | Internal Medicine | $157.18 |
| Michael Kobernick | Warren, MI | Emergency Medicine | $157.18 |
| Timothy Bailey | Escondido, CA | Endocrinology, Diabetes & Metabolism | $75.80 |
| Stephen Brunton | Winnsboro, SC | Family Medicine | $75.80 |
| Eden Miller | Bend, OR | Family Medicine | $75.80 |
Prescribed Afinion Hba1c Dx?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.